- Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales
- Annual General Meeting of Kuros Biosciences approves all resolutions
- Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
- Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update
Key statistics
On Thursday, Kuros Biosciences AG (KURN:SWX) closed at 7.96, -5.24% below its 52-week high of 8.40, set on Apr 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.07 |
---|---|
High | 8.38 |
Low | 7.70 |
Bid | -- |
Offer | 8.00 |
Previous close | 8.08 |
Average volume | 182.81k |
---|---|
Shares outstanding | 36.92m |
Free float | 23.93m |
P/E (TTM) | -- |
Market cap | 293.90m CHF |
EPS (TTM) | -0.3697 CHF |
Data delayed at least 15 minutes, as of May 16 2024.
More ▼